Guardion Health Sciences, Inc. (GHSI)
USD 3.22
(0.0%)
USD 3.22
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -6.35 Million USD | 40.29% |
| 2022 | -10.65 Million USD | -161.85% |
| 2021 | -4.06 Million USD | 49.68% |
| 2020 | -8.08 Million USD | 23.22% |
| 2019 | -10.52 Million USD | -1469.3% |
| 2018 | -670.94 Thousand USD | 85.74% |
| 2017 | -4.7 Million USD | -53206.39% |
| 2016 | 8859.00 USD | -98.83% |
| 2015 | 757.68 Thousand USD | -55.99% |
| 2014 | 1.72 Million USD | 66.91% |
| 2013 | 1.03 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -5.6 Million USD | 11.87% |
| 2024 Q2 | -14.82 Million USD | -164.46% |
| 2023 Q4 | -6.35 Million USD | 16.95% |
| 2023 Q2 | -8.36 Million USD | 4.66% |
| 2023 FY | -6.35 Million USD | 40.29% |
| 2023 Q3 | -7.65 Million USD | 8.47% |
| 2023 Q1 | -8.77 Million USD | 17.62% |
| 2022 Q2 | -4.2 Million USD | 12.52% |
| 2022 Q1 | -4.81 Million USD | -18.29% |
| 2022 FY | -10.65 Million USD | -161.85% |
| 2022 Q4 | -10.65 Million USD | 17.66% |
| 2022 Q3 | -12.93 Million USD | -207.32% |
| 2021 Q2 | -5.14 Million USD | 88.01% |
| 2021 Q3 | -3.24 Million USD | 36.86% |
| 2021 Q4 | -4.06 Million USD | -25.17% |
| 2021 Q1 | -42.93 Million USD | -431.11% |
| 2021 FY | -4.06 Million USD | 49.68% |
| 2020 Q2 | -11.09 Million USD | 10.12% |
| 2020 Q3 | -9.32 Million USD | 15.96% |
| 2020 Q4 | -8.08 Million USD | 13.28% |
| 2020 Q1 | -12.34 Million USD | -17.2% |
| 2020 FY | -8.08 Million USD | 23.22% |
| 2019 Q3 | -4.97 Million USD | -182.51% |
| 2019 FY | -10.52 Million USD | -1469.3% |
| 2019 Q4 | -10.52 Million USD | -111.49% |
| 2019 Q2 | -1.76 Million USD | -404.68% |
| 2019 Q1 | 578.4 Thousand USD | 186.21% |
| 2018 Q3 | -993.77 Thousand USD | 49.01% |
| 2018 Q4 | -670.94 Thousand USD | 32.48% |
| 2018 FY | -670.94 Thousand USD | 85.74% |
| 2018 Q1 | -3.06 Million USD | 34.93% |
| 2018 Q2 | -1.94 Million USD | 36.34% |
| 2017 Q2 | -126.41 Thousand USD | 53.92% |
| 2017 Q1 | -274.35 Thousand USD | -3196.9% |
| 2017 FY | -4.7 Million USD | -53206.39% |
| 2017 Q4 | -4.7 Million USD | -300.34% |
| 2017 Q3 | -1.17 Million USD | -829.66% |
| 2016 Q1 | 32.8 Thousand USD | -96.86% |
| 2016 FY | 8859.00 USD | -98.83% |
| 2016 Q4 | 8859.00 USD | -99.29% |
| 2016 Q3 | 1.24 Million USD | 1.88% |
| 2016 Q2 | 1.22 Million USD | 3636.22% |
| 2015 Q1 | 15.76 Thousand USD | -99.08% |
| 2015 Q4 | 1.04 Million USD | 36.86% |
| 2015 Q3 | 763.2 Thousand USD | 0.0% |
| 2015 FY | 757.68 Thousand USD | -55.99% |
| 2014 FY | 1.72 Million USD | 66.91% |
| 2014 Q4 | 1.72 Million USD | 0.0% |
| 2013 FY | 1.03 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Journey Medical Corporation | -9.7 Million USD | 34.497% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 106.751% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 108.485% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 101.47% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 59.323% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 59.323% |
| SCYNEXIS, Inc. | -19.35 Million USD | 67.134% |
| Safety Shot Inc | -2.28 Million USD | -178.398% |
| Alpha Teknova, Inc. | 1.97 Million USD | 422.171% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 101.461% |
| Bright Green Corporation | 1.84 Million USD | 445.309% |
| Dynavax Technologies Corporation | 106.63 Million USD | 105.964% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 101.386% |
| Cosmos Health Inc. | 8.59 Million USD | 174.029% |
| PainReform Ltd. | -7.95 Million USD | 20.004% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 32.558% |
| Embecta Corp. | 1.31 Billion USD | 100.485% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 95.139% |
| Procaps Group, S.A. | 242.93 Million USD | 102.618% |
| Theratechnologies Inc. | 24.87 Million USD | 125.571% |
| Harrow Health, Inc. | 116.41 Million USD | 105.463% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | -152.367% |
| Biofrontera Inc. | 4.05 Million USD | 256.796% |
| DURECT Corporation | -7.65 Million USD | 16.911% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 81.031% |
| Cronos Group Inc. | -663.32 Million USD | 99.041% |
| OptiNose, Inc. | 58.06 Million USD | 110.953% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 101.02% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 56.357% |
| RedHill Biopharma Ltd. | -5.18 Million USD | -22.63% |
| Organogenesis Holdings Inc. | 15.01 Million USD | 142.361% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | 6051.437% |
| Radius Health, Inc. | 359.28 Million USD | 101.77% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | 3324.825% |
| ProPhase Labs, Inc. | 19.23 Million USD | 133.07% |
| Phibro Animal Health Corporation | 454.84 Million USD | 101.398% |
| Procaps Group S.A. | 242.93 Million USD | 102.618% |
| Alvotech | 1.06 Billion USD | 100.598% |
| TherapeuticsMD, Inc. | 3.67 Million USD | 272.91% |
| Viatris Inc. | 17.13 Billion USD | 100.037% |
| Rockwell Medical, Inc. | 4.45 Million USD | 242.721% |
| Aytu BioPharma, Inc. | -4.87 Million USD | -30.401% |
| SIGA Technologies, Inc. | -148.68 Million USD | 95.723% |
| Tilray Brands, Inc. | 158.97 Million USD | 104.0% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 105.217% |
| Shineco, Inc. | 29.29 Million USD | 121.712% |
| PetIQ, Inc. | 351.93 Million USD | 101.807% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | -119.19% |
| Incannex Healthcare Limited | -5.48 Million USD | -15.946% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 103.587% |
| Alimera Sciences, Inc. | 55.3 Million USD | 111.498% |
| Silver Spike Investment Corp. | -32.61 Million USD | 80.499% |
| Assertio Holdings, Inc. | -32.52 Million USD | 80.449% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | -327.188% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | -25.675% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | -32.107% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 22.571% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | 250.81% |
| Hempacco Co., Inc. | 13.61 Million USD | 146.712% |
| Talphera, Inc. | -5.72 Million USD | -11.163% |
| Alvotech | 1.06 Billion USD | 100.598% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | 189.008% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 93.424% |
| Currenc Group, Inc. | -16.57 Million USD | 61.627% |
| Kamada Ltd. | -46.43 Million USD | 86.303% |
| Indivior PLC | -33.95 Million USD | 81.269% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | 2540.63% |
| Flora Growth Corp. | -713 Thousand USD | -791.956% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 22.571% |
| Evolus, Inc. | 63.7 Million USD | 109.982% |
| HUTCHMED (China) Limited | -197.45 Million USD | 96.779% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 101.327% |
| Akanda Corp. | 3.9 Million USD | 262.863% |